Ireland has unveiled seven major new Rinn centres backed by a combined investment of €460m, marking one of the largest research and innovation funding commitments in the nation’s history.
The announcement was made on June 10, 2026, by the Minister for Further and Higher Education, Research, Innovation and Science, James Lawless TD, as part of a national strategy to strengthen Ireland’s position in advanced scientific research and technology development.
The new Rinn centres will operate within a newly launched national research network, "Rinn" (an Irish word meaning "point," "tip," or "headland"), which brings together leading universities, institutes, and research organisations in a coordinated framework.
The initiative is designed to increase collaboration, improve governance, and attract greater international engagement across key scientific sectors. The massive funding injection is expected to create 577 research positions, support the development of more than 800 PhD graduates, and leverage a further €500m in funding from industry and other sources, bringing the ecosystem's total value to nearly €1 billion.
More than 200 industry partners, including multinational corporations and small and medium-sized enterprises, are already involved in the initiative.
"A Powerful Statement of Ambition"
Commenting on the landmark funding, Minister Lawless stated:
“The scale and scope of this €460m investment is a powerful statement of Ireland’s ambition in research and innovation. Research Ireland centres have, over the last 13 years, fundamentally reshaped our innovation landscape – turning excellent and innovative research into real-world societal and economic impact. Our higher education institutions and enterprise collaborators have been critical to that success."
“With these seven new Rinn, we are building on this progress by supporting talent, strengthening industry partnerships, attracting foreign direct investment, advancing indigenous industry growth, promoting regional development, and enabling Ireland to remain internationally competitive,” the Minister added.
The 7 Strategic Research Hubs
The seven newly funded Rinn centres will focus on areas identified as critical to Ireland’s future economic competitiveness and technological leadership. The allocations are as follows:
- Advanced Therapies: €51.1m
- Artificial Intelligence (Rinn AI): €121.8m
- Energy System Decarbonisation: €51.8m
- Medical Devices: €64.5m
- Pharma and Biopharma Manufacturing: €60.3m
- Quantum Science and Technology: €39.6m
- Semiconductor Systems: €71m
AI received the largest allocation of €121.8m, reflecting the growing importance of Artificial Intelligence research and its central role in national digital transformation strategies.
National Collaboration on an Unprecedented Scale
Seventeen research-performing organisations will participate in the network, including universities, technological universities, specialist research institutes, and industry-focused innovation centres.
Participating institutions include Trinity College Dublin, University College Dublin, University College Cork, University of Galway, Dublin City University, Maynooth University, University of Limerick, and several technological universities across the country.
The network also includes the Tyndall National Institute, the National Institute for Bioprocessing Research and Training (NIBRT), and the Economic and Social Research Institute (ESRI). The sheer scale of participation is intended to create a more unified national research ecosystem capable of competing internationally while delivering economic and societal benefits within Ireland.
Supporting National Innovation Strategies
The Rinn centres are closely aligned with several long-term government policies, including the Programme for Government, the National Development Plan, Impact 2030, Quantum 2030, and Ireland’s National Semiconductor Strategy, known as “Silicon Island”.
Furthermore, the AI and quantum centres are expected to play a highly central role in delivering objectives outlined in Digital Ireland, the country’s recently launched National Digital and AI Strategy.
The seven Rinn centres were selected following a highly competitive funding process involving independent international expert evaluation. Their activities will officially begin on July 1, 2026, ushering in a new phase of coordinated research investment that aims to deliver long-term scientific, economic, and societal impact both nationally and internationally.
Collaborative Ecosystems: Bridging Academy and Industry
The establishment of the seven new "Rinn" research centres represents a cornerstone of Ireland's long-term science and technology policy. Funded through Science Foundation Ireland (SFI) and industry partners, these centres will focus on cutting-edge research in digital therapeutics, smart manufacturing, sustainable chemistry, and climate technology. By co-locating academic researchers and industry engineers, the centres aim to accelerate the commercialization of new technologies, creating high-value startups and reinforcing Ireland's competitiveness as a global innovation hub.
Frequently Asked Questions
What is the "Rinn" research centre initiative?
It is a €460 million state-industry partnership establishing seven specialized research centres across Ireland to drive innovation in tech, health, and green chemistry.
Who provides the funding for these research centres?
The funding is co-financed by the Irish government (via Science Foundation Ireland) and private enterprise partners who collaborate on specific research projects.
Which universities are hosting these new centres?
Leading research institutions, including Trinity College Dublin (TCD), University College Dublin (UCD), UCC, and the University of Limerick (UL), are hosting the centres.
National Research Funding and Tech Transfer
The €460 million Rinn research centres program is a strategic investment in the future of the Irish knowledge economy. By aligning national research funding with commercial MedTech and digital health clusters, Ireland accelerates the commercialization of scientific discoveries. Fostering a seamless technology transfer pathway from labs to clinical applications is key to keeping the sector competitive globally.
